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Abstract
Background: Depressive and anxiety disorders are common in general practice but not always treated adequately.
Introducing stepped care might improve this. In this randomized trial we examined the effectiveness of such a
stepped care model.
Methods: The study population consisted of primary care attendees aged 18-65 years with minor or major DSM-IV
depressive and/or anxiety disorders, recruited through screening. We randomized 120 patients to either stepped
care or care as usual. The stepped care program consisted of (1) watchful waiting,( 2 )guided self-help, (3) short face-
to-face Problem Solving Treatment and (4) pharmacotherapy and/or specialized mental health care. Patients were
assessed at baseline and after 8, 16 and 24 weeks.
Results: Symptoms of depression and anxiety decreased significantly over time for both groups. However, there
was no statistically significant difference between the two groups (IDS: P = 0.35 and HADS: P = 0.64). The largest,
but not significant, effect (d = -0.21) was found for anxiety on T3. In both groups approximately 48% of the
patients were recovered from their DSM-IV diagnosis at the final 6 months assessment.
Conclusions: In summary we could not demonstrate that stepped care for depression and anxiety in general
practice was more effective than care as usual. Possible reasons are discussed.
Trial Registration: Current Controlled Trails: ISRCTN17831610.
Background
Depressive and anxiety disorders are common in general
practice [1]. These disorders are often associated with
serious functional impairment, reduced quality of life
[2,3], high levels of service use and rising economic costs
[4,5]. Persons with depressive and anxiety disorders often
seek help in primary care [6]. Although evidence based
clinical guidelines are available for the treatment of
depressive and anxiety disorders in primary care [7,8],
initiation of, and adherence to effective treatment is
usually poor [9-12]. An important problem is the under-
recognition of these disorders [13]. For depression
approximately half of all patients are not recognized by
their general practitioner (GP) as having psychological
problems [14,15]. For anxiety disorders this is about 75%
[ 1 6 ] .A n o t h e rp r o b l e mi st h a tm o s tp a t i e n t sw h od o
receive treatment, receive antidepressants [17-19], whilst
the majority of primary care patients prefer psychother-
apy as a treatment [20]. Furthermore, antidepressants are
often prescribed in relatively mild cases even though it
has been established that medication is not effective in
these patients [21,22]. Given these problems and the fact
that depressive and anxiety disorders have a high burden
of disease, there is a need for better managed and struc-
tured treatment in primary care.
Recent studies of treating depression and anxiety have
proposed several models of disease management [23], col-
l a b o r a t i v ec a r e[ 2 4 ]a n ds t e p p e dc a r e[ 2 5 ] .O n ec o r ee l e -
ment of these models is the presence of a care manager
who is responsible for managing the care that the patient
receives. Another core element is the establishment of a
more integrated cooperation between primary care and
specialized mental health care [26]. The stepped care
model could provide a solution for the problem of apply-
ing effective, evidence-based care for depression and anxi-
ety in primary care through its objective of initiating
interventions at the right time and as adequately as possi-
ble. Care is offered not earlier or more intensely than
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[25,27]. In a stepped care model, all eligible patients start
with an evidence-based treatment of low intensity as a
first step. Progress is monitored and patients who do not
respond adequately can ‘step up’ to a subsequent treat-
ment of higher intensity [28]. This model is suitable in
(primary) mental health care because the proposed treat-
ments in the most recent depression guidelines, published
in the Netherlands in 2009, range from less intensive
interventions like psychoeducation or self help interven-
tions (individual or group courses), problem solving treat-
ment (PST), to more intensive treatments such as
cognitive behavioral therapy and pharmacotherapy.
Another important feature of the stepped care model is
that the model is self-correcting. Self-correcting means
that the results of treatments and decisions about treat-
ment provisions are monitored systematically and neces-
sary changes are made (’stepping up’) if current treatments
are not achieving significant health improvement [25]. A
care manager coordinates a stepped care program, prefer-
ably a nurse or social worker who supports the primary
care clinic handling psychiatric problems. In The Nether-
lands the most likely candidate for this role is a psychiatric
nurse working in primary care. This care manager moni-
tors the patients, provides the first treatments in the
stepped care model and refers the patient to the appropri-
ate mental health care specialist if necessary.
Stepped care models have been developed for different
health problems, for example eating disorders [29,30],
alcohol related disorders [31,32], smoking cessation [33]
and prevention of anxiety and mood disorders in elderly
[34]. At present stepped care is recommended for health
care in several guidelines, for example in the NICE guide-
lines for anxiety, depression and obsessive compulsive dis-
order and in the depression guidelines in the UK (NHS)
[35-37] and by the ministry of health in New Zealand in
2009 [38]. Although there is some supportive evidence for
stepped care, there are few randomised trials to demon-
strate convincing evidence and evaluations of this
program.
The aim of this study is to examine the effectiveness
of a stepped care model in primary care via a rando-
mized controlled trial for patients with depressive and/
or anxiety disorders. We will examine the reduction of
symptoms, recovery and the speed of recovery.
Methods
Study design
The methods of this study have been published pre-
viously [39]. In short, 120 participants were recruited
through 32 primary care practices. They were randomly
assigned into two groups: stepped care or care as usual.
We chose a pragmatic design because we wanted to
study the effects of the intervention among typical
patients in a real-life setting because this increases exter-
nal validity [40,41]. This means that we implemented a
stepped care model in general practice in collaboration
with specialized mental health care centres. Treatment of
mental health in primary care is common in The Nether-
lands. A recent development is to establish a psychiatric
nurse or psychologist in general practice. The GP can
refer patients within his own practice to a professional
instead of direct referral to specialized mental health
care. Inclusion took place between April 2007 and May
2008. The study was approved by the Medical Ethical
Committee of the VU Medical Center and all participants
gave written, informed consent. The effectiveness of the
first step of this stepped care model (guided self-help)
has been reported separately [42]. Self-help and bib-
liotherapy seem promising low intensity treatments for
depression and anxiety in several studies, but there are
few studies that report results on guided-self help in gen-
eral practice, therefore these relevant results are reported
separately, with the focus on self-help/bibliotherapy in
primary care. These data were derived from a larger pro-
ject (stepped care) and the outcomes of this whole pro-
ject are reported in this paper.
Inclusion and exclusion criteria
We included adults aged 18-65 years with one or more of
the following DSM-IV [43] diagnoses: major depression
(single episode or recurrent), dysthymia, panic disorder
(with or without agoraphobia), social phobia or general-
ized anxiety disorder. We also included patients with a
minor depression or a minor anxiety disorder. DSM-IV
research criteria were used to define minor depression.
For minor depression only two to four out of the nine
DSM-IV symptoms had to be present, of which at least
one had to be a core symptom (depressed mood or mark-
edly diminished interest or pleasure in all, or almost all,
activities). As there are no DSM-IV criteria for minor
anxiety we defined this as a score of 12 or more on the
Hospital Anxiety and Depression Scale (HADS) [44] and
dysfunctioning in daily life (household, work, social rela-
tions and/or social activities). Patients were excluded in
case of a psychotic or bipolar disorder, current (< 2
months) treatment (medical/psychotherapy) for psycholo-
gical problems, prominent suicide ideation, severe alcohol
problems (> 20 on the Alcohol Use Disorders Identifica-
tion Test (AUDIT) [45], no motivation for treatment or
insufficient knowledge of the Dutch language.
Recruitment
Recruitment of GPs
In this study we collaborated with two mental health
centres in Amsterdam (GGZ inGeest and Mentrum).
Both of these mental health centres employ psychiatric
nurses and psychologists, who work for a few hours per
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these psychiatric nurses/psychologists for short-term
treatments. First we approached the psychiatric nurses
and psychologists and after they consented we invited
the corresponding GPs to collaborate in this study. In
total we included 32 GPs in 18 general practices.
Recruitment of patients
Patients were recruited by sending all patients of the parti-
cipating GPs a screening questionnaire. All patients with a
positive screener for depression and/or anxiety were
assigned to a watchful waiting period of 4 weeks. After 4
weeks all patients were screened again to exclude the
patients who recovered spontaneously. This second
screener was included in the baseline questionnaire (T0)
and was sent to all patients together with general informa-
tion about the project and an informed consent form. All
eligible patients were approached for a diagnostic inter-
view (Composite International Diagnostic Interview
(CIDI) [46] by telephone to check the in- and exclusion
criteria. Patients who met the inclusion criteria and
returned their informed consent were randomized. One
hundred twenty patients were included.
Number of patients
Before the start of the study we calculated that we needed
2*100 patients in order to be able to detect clinically rele-
vant difference (d = 0.40) with a power of 80% and an
alpha of 0.05 [47]. However, inclusion was slower than we
expected and therefore we included only 120 patients [Fig-
ure 1]. In total we send 34.906 screeners and had a
response of 17.4%. Of the 1105 patients who scored posi-
tively on the first screener, 335 (30.3%) declined to partici-
pate any further and 301 (27.3%) could not be reached or
did not respond. Of the remaining 469 patients, 294
(62.6%) were excluded (most given exclusion reason: cur-
rent or recent (< 2 months) psychological or pharmacolo-
gical treatment), 55 patients (11.7%) were recovered and
scored negatively on the second screener and 120 patients
(25.6%) were included.
Randomization
We randomized patients at an individual level. They
were randomized into two groups and we used blocks
of 4 to prevent overburdening the care managers. Care
managers were not informed about patients who were
randomized to care as usual. An independent researcher,
not involved in the current project, used computer gen-
erated block randomization to produce sealed envelopes.
After every inclusion the researcher opened a sealed
envelope. We randomized 60 patients to the stepped
care program and 60 patients to care as usual.
Intervention
The stepped care intervention consisted of four steps: (1)
watchful waiting. The patients received no treatment for
four weeks. In this project, as mentioned earlier, only
patients who still showed symptoms of depression and/or
anxiety after the watchful waiting period were included.
The included patients started with (2) guided self-help.
Self-help can be defined as a standardized psychological
treatment that a patient can work through on his/her
o w n ,p o s s i b l yw i t hs o m eg u i d a n c e[ 4 8 ] .M o s ts e l f - h e l p
interventions are based on cognitive-behavioural therapy
(CBT) [49] but nowadays other types of treatment (i.e.
problem solving treatment (PST), interpersonal psy-
chotherapy (IPT) have become available as (guided) self-
help interventions as well. Self-help interventions are
available via books (bibliotherapy) and via the computer
(web-based, CD-ROM, DVD) and they can be pure self-
help or guided self-help. In this first step guided self-help
was introduced in a 30 minute session with a care man-
ager. This session enabled the care manager to check
exclusion criteria, give psychoeducation (e.g., advice on
lifestyle) and to explain the self-help interventions. In
this study we used two different self-help interventions.
The first was a generic intervention based on problem
solving treatment. Previous studies have demonstrated
the effectiveness of this intervention among people in
general population with symptoms of depression and/or
anxiety [50,51]. This intervention was available as a book
and through the Internet. The patient could choose to
get feedback by email or by telephone. The feedback was
given by junior psychologists. They were trained by the
senior researcher (AvS). The feedback is not therapeutic
in nature and was primarily aimed at helping people to
understand the techniques which are offered in the
course. Furthermore, the feedback is used to motivate
people to continue the course. The feedback is designed
as being easy to learn by, for example, a care manager or
psychiatric nurse. The second self-help intervention was
specifically aimed at patients with phobias and was based
on exposure therapy. This course also took six weeks to
complete and was only available in book form. Feedback
was therefore provided by telephone. During the first
face-to-face session with the care manager it was decided
which self-help course was most suitable. Patients who
did not recover from self-help treatment started with (3)
face-to-face Problem Solving Treatment (PST).P S Ti sa
short psychological intervention, 5 sessions of 45 minutes
each, provided by the care manager in the primary care
practice [52]. The treatment protocol was based on the
protocol as described by Mynors-Wallis [53]. Patients
who were unresponsive to this treatment proceeded to
t h el a s ts t e po ft h es t e p p e dc a r ep r o g r a m( 4 )pharma-
cotherapy and/or referral for specialized mental health
care. When patients did not recover from PST they
had one more session with the care manager and dis-
cussed the next step: either pharmacotherapy or more
specialized mental health care. The care manager was
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the GP or in mental health care). Before the start of the
study it was agreed with the specialized mental health
care centers that patients from this study could directly
start with psychological treatment. They could skip nor-
mal intake procedures as well as waiting lists.
Exceptions
Even though there is no clear evidence that patients
with more severe symptoms of anxiety or depression do
not benefit from low intensity (self-help) interventions,
we decided that patients with more severe disorders
should be referred to more specialized mental health
Figure 1 Flowchart inclusion and randomization.
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ceding steps. Severity of the disorders was based on
questions about daily functioning on the Work and
Social Adjustment Scale (WSAS) [54]. If the patient
experienced extreme dysfunctioning (score of 8 or
higher) on minimal three of the four domains (house-
hold, work, social relations and social activities) he/she
was directed immediately to the fourth step of the
stepped care program.
Care as Usual
Patients randomized to the ‘care as usual’ were advised
to see their GP to discuss treatment options. The GP is
very easy accessible in The Netherlands, due to good
health insurance for everyone. Most patients go to their
GP with mental health complaints. The GP is a gate-
keeper for secondary (specialized) mental health care.
Assessments and definition of recovery
After each step in the stepped care intervention, i.e.
after every 8 weeks, patients were monitored. We
assessed symptoms of depression and anxiety as well as
daily functioning. We considered a patient to be recov-
ered when he/she scored less than 14 on the Inventory
of Depressive Symptomatology (IDS) [55], and scored
less than 8 on the HADS [44]and scored less than 6 on
the WSAS [54]. This criterion was based on several stu-
dies [55-58].
Instruments
Depressive symptoms
We used the Inventory of Depressive Symptomatology
(IDS) to measure depressive symptoms. The IDS con-
sists of 30 items and the total score varies between 0
and 79. Scores below 14 indicate an absence of depres-
sive symptoms. We used this cut-off score as an indica-
tion for recovery from depressive symptoms [55,56].
Internal consistency is high for the IDS (Cronbach’s
alpha: 0.92) [55].
Anxiety symptoms
For identifying anxiety symptoms we used the Hospital
Anxiety and Depression Scale (HADS) [44] which is
designed to identify anxiety disorders among patients in
non psychiatric settings. The HADS consists of 7 items.
Item responses are on a 0 to 4 scale (0 = “none” and
higher ratings reflect greater degrees of symptom severity).
Total scores range from 0 to 21. The HADS showed good
homogeneity and reliability, with Cronbach’s alpha ranging
from 0.81 to 0.84 in various clinical and non-clinical
Dutch samples [59].
Dysfunction
We measured daily functioning of the patient via four
questions on the Work and Social Adjustment Scale
(WSAS) [60]. Using this questionnaire, the patient gives
an estimate, on a scale from 1 to 10, of the perceived
dysfunctioning in his or her daily life. The questions
contain four domains: household tasks, work, social rela-
tions and social activities.
Composite International Diagnostic Interview (CIDI)
The CIDI (version 2.1), a structured interview developed
by the World Health Organisation [46], enables trained
interviewers to assess psychiatric diagnosis defined in the
DSM-IV [43]. The assessment typically lasts 30 to 75 min-
utes, depending on the mental state of the respondents
[61]. In this study, current mental status (last six months)
is taken into consideration. The interviews were con-
ducted by psychology master students who had followed a
CIDI-training. Interviewers were blind regarding randomi-
zation at the follow-up assessment.
Statistical Analysis
All analyses were conducted according to the intention-to-
treat principle. Missing data were imputed using regres-
sion imputation, except for the Generalized Estimating
Equations (GEE)-analysis because imputation is part of the
analysis. The effectiveness of stepped care compared to
care as usual is expressed in different ways. First we used
t-tests to determine if there were any statistically signifi-
cant differences between the test scores on every assess-
ment of the two groups, to see if they showed any
statistically differences (P-values). Second, we calculated
effect sizes (Cohen’s d [47]). This was done for every
assessment by subtracting the post-test mean score of the
control group from the post-test mean of the intervention
group. This difference in mean scores is divided by the
pooled, over time and group, standard deviation. A
Cohen’s d of 0.5 thus indicates that the mean of the inter-
vention group is half a standard deviation larger than the
mean of the control group. Values of d from 0.56 to 1.2
can be assumed to be large, 0.33 to 0.55 are moderate, and
0 to 0.32 are small [62]. Second, we assessed the differ-
ences between the assessments by means of Generalized
Estimating Equations (GEE) [63]. The method of GEE is
often used to analyze longitudinal and other correlated
response data. GEE takes into account the correlational
nature of repeated measures data within subjects, and
securing minimal loss of patients due to incomplete data.
We included time as a continuous variable. And third, we
examined differences in the percentages of patients who
recovered from their diagnosis at the last assessment.
Results
Baseline characteristics
Almost two thirds of the included participants were
women (65%) and the mean age (SD) was 50.2 (SD =
11.2) years. At baseline, the mean IDS score was 30.6
(SD = 10.8) and the mean HADS score was 9.7 (SD =
4.0) [Table 1]. This is for both depression and anxiety a
mild to moderate mean score. Twelve (9.9%) of the 120
randomized participants reported severe dysfunctioning
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to stepped care. Those 5 patients proceeded directly to
the fourth step and did not receive a self-help interven-
tion. We also referred 4 patients without severe dysfunc-
tioning to specialized mental health care based on the
judgment of the psychiatric nurse. There were no signif-
icant differences between the stepped care and control
group on any of the demographic or clinical variables.
Treatment adherence
Of the 60 stepped care patients, 44 (73.3%) received a
first face-to-face meeting with the psychiatric nurse and
received a self-help course and 9 (15%) were referred
directly after inclusion to the fourth step. There were 7
(11.7%) patients who left the stepped care program (3
were physical ill and 4 could not be reached when the
psychiatric nurse tried to make an appointment). After
self-help 4 of the 44 (9.1%) patients were recovered and
23 (55.3%) patients left during the program. Different
reasons were given for leaving the program, for example
they felt better, were physical impaired, they moved,
received other care, were disappointed in care or pre-
ferred face-to-face treatment. Seventeen of the 44
(40.5%) patients moved to the next step and received
PST. Five of 17 (29.4%) left the program during PST
(mostly the same reasons were given as after the first
step) and did also not want to receive specialized mental
health care. After PST 5 (29.4%) patients were recov-
ered. Seven of 17 (41.2%) patients were referred to spe-
cialized mental health care after they had run through
the whole stepped care program and after referral. For
these patients we arranged an intake in specialized men-
tal health care. Four of the seven patients received care
in a matching program (for example mood or anxiety).
One patient did not want to be referred and two
patients did not need specialized mental health care
according to themselves in agreement with their psy-
chiatric nurse. One of the 7 referred patients (14.3%)
has recovered at time of the last assessment [Figure 2].
GPs were asked to refrain from offering any treatment
to patients who were included in the stepped care group
(treatment group). Benzodiazepines were allowed in
both study groups. Patients in the stepped care group
were only allowed to receive antidepressants in later
phase of the treatment protocol. Table 2 describes the
received care as usual for the patients in this group
between the steps of the model. It shows that half of the
patients went to see their GP and on average 25%
received mental health care. Only one patient (2.4%)
received antidepressants during the last step.
Treatment effects: effect size
When we compared stepped care and care as usual on
IDS on each measurement, we could not demonstrate
Table 1 Baseline characteristics
Total
n (%)
Stepped care
n (%)
Care as usual
n (%)
P
Demographics
Participants 120 (100%) 60 (100%) 60 (100%)
Mean age, years (SD) 50.2 (11.2%) 51.2 (9.8%) 49.2 (12.4%) 0.13
Gender (female) 78 (65.0%) 41 (68.3%) 37 (61.7%) 0.44
With a paid job 69 (57.5%) 33 (55.0%) 36 (60.0%) 0.58
Born in The Netherlands 95 (80.5%) 49 (81.7%) 46 (79.3%) 0.50
Married 40 (33.3%) 18 (30.0%) 22 (36.7%) 0.44
Clinical status
Depression (IDS, mean (SD)) 30.7 (10.8%) 29.5 (11.3%) 31.8 (10.3%) 0.24
Anxiety (HADS, mean (SD))
a 9.7 (4.0%) 9.7 (4.1%) 9.8 (4.0%) 0.91
DSM-IV diagnosis
Anxiety
Any anxiety disorder 110 (91.7%) 55 (91.7%) 55 (91.7%) 1.00
Only anxiety disorder 51 (42.5%) 30 (50.0%) 21 (35.0%) 0.10
Depression
Any depressive disorder 69 (57.5%) 30 (50.0%) 39 (65.0%) 0.10
Only depressive disorder 10 (8.3%) 5 (8.3%) 5 (8.3%) 1.00
Comorbid depressive and anxiety disorder 59 (49.2%) 25 (41.7%) 34 (56.7%) 0.10
Mean age of onset DSM-IV diagnosis (SD)
b 28.3 (16.0) 28.8 (15.5) 27.8 (16.5) 0.75
HADS = Hospital Anxiety and Depression Scale, IDS = Inventory of Depressive Symptomatology,
an = 107 (one missing HADS),
bn = 100 (eight patients with
unofficial DSM-diagnosis)
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0.24, T1: P = 0.49, T2: P =0 . 8 6a n dT 3 :P =0 . 5 5 ) .
When we compared stepped care and care as usual on
the HADS on each measurement, we did not find any
significant differences between the groups either (T0: P
= 0.91, T1: P =0 . 4 7 ,T 2 :P =0 . 7 1a n dT 3 :P =0 . 2 2 ) .
The largest, but not significant, effect (d = 0.21) was
found for anxiety on T3 [Table 3].
Figure 2 Stepped care program flow chart.
Table 2 Received treatment in care as usual per
assessment
Type of treatment T0 - T1 T1 - T2 T2 - T3
n =3 8 n =3 7 n=42
GP 21 (55.0%) 19 (31.7%) 24 (57.1%)
Mental health care 10 (26.0%) 9 (24.3%) 12 (28.6%)
Medical officer 2 (5.0%) 1 (2.7%) 2 (4.8%)
Social worker 1 (3.0%) 2 (5.4%) 4 (9.5%)
Alternative medicine 4 (11.0%) 2 (5.4%) 1 (2.4%)
Benzodiazepines 9 (24.2%) 7 (18.9%) 3 (7.1%)
Antidepressants 0 (0.0%) 0 (0.0%) 1 (2.4%)
Table 3 Observed means, SDs, p-values and Cohen’sdo n
the IDS and HADS
Stepped care Care as usual Pd
n =6 0 n =6 0
T0
IDS 29.5 (11.3) 38.8 (10.3) 0.24
HADS 9.7 (4.1) 9.8 (4.0) 0.91
T1
IDS 25.6 (12.3) 27.2 (12.9) 0.49 0.12
HADS 8.7 (4.3) 9.3 (3.8) 0.47 0.14
T2
IDS 25.0 (13.0) 25.4 (11.0) 0.86 0.03
HADS 9.8 (3.8) 9.1 (3.7) 0.71 0.05
T3
IDS 25.0 (12.5) 25.4 (13.0) 0.55 0.11
HADS 7.9 (3.7) 8.8 (4.2) 0.22 0.21
IDS = Inventory of Depressive Symptomatology
HADS = Hospital Anxiety and Depression Scale
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Depression (IDS)
GEE-analysis indicated that depressive symptoms signifi-
cantly decrease over time in both the stepped care and
care as usual condition (P < .01). But there was no sig-
nificant difference between both groups (P =0 . 3 5 )a n d
no interaction effect between time and group (P =0 . 8 2 )
(B = 0.17; 95% CI = -1.33 to 1.68).
Anxiety (HADS)
GEE-analysis indicated a significant decrease of anxiety
symptoms in both stepped care and care as usual over
time (P < 0.01). But there was no significant difference
between both groups (P = 0.64) and no interaction
effect between time and randomization (p = 0.10) (B =
-0.45; 95% CI = -0.98 to 0.09).
Treatment effect: diagnoses
There was no statistically significant difference between
the percentage recovered in the stepped care group (n =
18; 47.4%) and the care as usual group (n = 20; 51.3%;
P = 0.73). We performed a sensitivity analyses. First we
assumed that all patients whose diagnosis was missing
had actually recovered (best case scenario). In this case
68.3% of the stepped care patients and 66.7% of the care
as usual patients were recovered. There was no differ-
ence in the percentage of recovery between the two
groups (P = 0.85). Second we assumed that all patients
whose diagnosis was missing still suffered from a
depression or anxiety disorder (worst case scenario). In
this case 33.3% of the stepped care patients and 30% of
the care as usual patients were recovered. Again, there
was no difference in the percentage of recovery between
the two groups (P = 0.70).
Discussion
We do not find any evidence that a stepped care model
outperformed care as usual. In both groups the levels of
symptoms declined, but there were no differences
between stepped care and care as usual. In both groups
approximately 50% still received a DSM-IV diagnosis six
months after inclusion.
T h e r em i g h tb es e v e r a lr e a s o n sw h ys t e p p e dc a r ed i d
not outperform care as usual in this trial. The following
reasons are discussed: recruitment and need for treat-
ment, motivation, mild symptoms, chronicity, adherence
and well developed care as usual. First of all, there was
little interest in participating in a stepped care model
given the difficulty of recruiting patients for this study.
The patients that were recruited might have been a
select group due to a selection bias through screening.
A recent meta-analysis of psychological treatment of
depression in primary care [64] demonstrated that stu-
dies with recruitment through screening are less effec-
tive than studies with recruitment through referral. The
authors suggest some explanations that might apply to
our study. Patients who do not actively seek treatment
might have good reasons for not seeking treatment
themselves. They might be different from those who
actively seek treatment in a number of ways but these
differences are as yet unknown. The patients in both
stepped care and care as usual had a, on average, mild
to moderate symptom levels, but the small change in
symptoms over time and the high number of existing
diagnosis at the end of the study suggests that we
included a chronic group of patients. Further evidence
for the chronicity in the study sample can be seen in
that the mean age of the sample is 50 years but the
mean age of onset is 28, suggesting an average 22 year
chronicity. This problem could be eliminated with refer-
ral through the GP by referring patients that would ben-
efit from a stepped care model and refer patients with
chronic mental problems to specialized mental health
care. Therefore stepped care can be applied for eligible
patients or for the prevention of anxiety and/or anxiety,
which is already been proven effective for elderly [34].
Prevention with low-intensity treatment could reduce
the development of a full-blown disorder.
Patients with relatively mild symptoms might have less
room for improvement compared to those with severe
symptoms and they also might be less motivated for
treatment and therefore show no decrease of symptoms.
This also could explain why the adherence to the stepped
care program was poor, in total 38 (63.3%) of 60 patients
dropped out of the stepped care model at a given time.
Certainly for the self-help step, in this step most patients
dropped out of the program. Apart from lack of motiva-
tion, the freedom of choice for feedback may have led to
no feedback requests. In previous research it has been
established that self-help without guidance is not effec-
tive. It is highly recommended to give more attention to
t h eg u i d a n c eo ft h es e l f - h e l pc o u r s e[ 6 5 ] .I no u rs t u d y
patients could choose if they wanted to receive feedback
on their assignments, but there is evidence that in inter-
ventions without a coach, compared to interventions
with a coach, the drop-out rate is considerably higher
[66]. To create a better adherence to the self-help course,
guidance by a coach should be considered. Another sug-
gestion for adjustment to create higher adherence to the
care model is to search for other low-intensity treatments
as a first step and, for example, give the patient a choice
between two or more treatments. In the Phase IV field
trial, described by Richards and Suckling [67], they com-
bine low-intensity stepped care psychological treatment
with a telephony-based collaborative care organizational
system. This would be a more flexible approach to
stepped care.
Our suggestion to improve the model would be to give
the patient a choice in the first step between low-intensity
Seekles et al. Trials 2011, 12:171
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Page 8 of 10treatments, for example: (guided) self-help and psycho-
education in few group-sessions or they might even
choose to skip the first step. This psychoeducational group
therapy (with: patient’s education, behavioural activation,
problem solving techniques) h a sb e e na ne f f e c t i v ef i r s t
step in a randomized controlled trial of treating severe
depression in primary care with a stepped care program
[68]. At last, the care as usual in The Netherlands is quite
well developed in terms of evidence-based guidelines,
mental health specialists working in primary care and it is
easily accessible for patients. Therefore, this study was not
a placebo control but has a good quality control group.
This might have led to no differences between both groups
and it might be that a stepped care model is not effective
for use in Dutch primary care.
Through the earlier mentioned problem with recruit-
ing patients for this study the power of this study was
also a limitation. We intended to include 200 patients,
but because of the problematic recruitment we only
were able to include 120 patients. Nevertheless we do
not think that an inclusion of 200 patients would have
changed our results given the small effects.
Conclusions
In summary we could not demonstrate that stepped care
for depression and anxiety in general practice was more
effective than care as usual. This model, with recruit-
ment through screening in patients with mild disorders
is not a good methodology. For further research on
stepped care we recommend recruitment of patients via
referral of the GP. Studies on care models and complex
interventions are of increasing importance because they
provide effective health care. More research is needed
on the development of mental health care models that
fit into the local care system.
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